CIK: 1625110 - Address: C/O Verve Therapeutics, Inc., 201 Brookline Avenue, Suite 601, Boston, MA 02215
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/1/23 16:30
11/29/23
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsDorval AllisonMAOCFOM.d00.0002864D
12/1/23 16:30
11/29/23
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsDorval AllisonMAOCFOS.d-611.450-1-124D
6/15/23 21:01
6/13/23
PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsDorval AllisonCADS-353.450-10-1944D
12/1/22 17:00
11/29/22
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsDorval AllisonMAOCFOM.d00.00026032D
12/1/22 17:00
11/29/22
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsDorval AllisonMAOCFOS.d-1222.100-1-202D
2/16/21 16:10
2/11/21
VYGRVoyager Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagDorval AllisonMAOCFOS-247.550-3-646D
1/14/21 17:57
1/12/21
VYGRVoyager Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagDorval AllisonMAOCFOS-258.620-3-649D
1/29/20 17:27
1/21/20
VYGRVoyager Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagDorval AllisonMAOCFOS-4213.360-3-1125D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact